Ameluz

Ameluz treats actinic keratoses on the face and scalp. It is recommended to avoid exposure to the sun for about 48 hours after treatment.

Ameluz Overview

Reviewed: May 31, 2016
Updated: 

Ameluz is a prescription medication used to treat mild to moderate actinic keratoses on the face and scalp. Ameluz is used in combination with photodynamic therapy (PDT) using BF-RhodoLED. BF-RhodoLED, considered a medical device, is a lamp that produces red light and activates the medication.

Ameluz belongs to a group of drugs called a porphyrin precursor. After being activated by BF-RhodoLED, Ameluz destroys the target cells. 

This medication is available as a gel and is administered by a health care provider. 

Common side effects include applicate site side effects such as pain/burning, irritation, and itching. 

 

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Ameluz Drug Class

Back to Top

Ameluz is part of the drug class:

Contributors

All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact support@rxwiki.com.